Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Microphthalmia, Isolated, with Coloboma 5 × silmitasertib × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Sarcoma, Ewing 1 Rhabdomyosarcoma 1 Osteosarcoma 1 Neuroblastoma 1 Microphthalmia, Isolated, with Coloboma 5 1 Medulloblastoma 1 Liposarcoma 1 Cholangiocarcinoma 1 Biliary Tract Neoplasms 1 Bile Duct Neoplasms 1

Interventions

silmitasertib 1 Temozolomide 1 HhAntag691 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03904862 2025-10-30

Testing the Safety and Tolerability of CX-4945 in Patients With Recurrent Medulloblastoma Who May or May Not Have Surgery

Pediatric Brain Tumor Consortium

Phase 1/2 Terminated

Microphthalmia, Isolated, with Coloboma 5, Medulloblastoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡